atm机转账美国FDA 医疗器械体系法规QSR820中文版
Part 820——质量体系法规——目录
Subpart A- 总则
820.1 范围
820.3 定义
820.5 质量体系
Subpart B –质量体系要求
820.20 管理职责
820.22 质量审核
血战日寇 820.25 人员
Subpart C- 设计控制
820.30 设计控制
Subpart D- 文件控制
820.40 文件控制
Subpart E- 采购控制
820.50 采购控制
Subpart F- 标识与可追溯性
820.60 标识
820.65 可追溯性
Subpart G - 生产和过程控制
820.70 生产和过程控制
820.72 检验、测量和试验设备
820.75 过程确认
Subpart H - 验收活动:
820.80 进货、过程和成品器械检验
820.86 检验状态
Subpart I – 不合格品
820.90 不合格品
Subpart J - 纠正和预防措施
820.100 纠正和预防措施
Subpart K – 标识和包装控制
820.120 设备标签
820.130 设备包装
Subpart L – 搬运/储存/分销和安装
820.140 搬运
820.150 贮存
820.160 分销
820.170 安装
Subpart L – 记录
820.180 记录的通用要求
820.181 设备主要记录
820.184 设备历史记录
820.186 质量体系记录
820.198 投诉文件
Subpart M – 服务
820.200 服务
Subpart N – 统计技术
820.250 统计技术
Subpart A——总则
Subpart A--General Provisions喜欢不一定要拥有
Sec.820.1 范围
Sec. 820.1 Scope.
（a） 适用性Applicability。
（1） 本质量体系法规阐明了当前良好一般代理权限内容制造法规Current good manufacturing practice（CGMP）的要求。本标准适用于所有预期用于人类的成品器械的设计、制造、包装、标
识、储存、安装和服务中所使用的管理方法、设施和控制。本标准的目的是保证成品器械的安全性和有效性，并符合联邦食品、药品和化妆品法案Federal Food, Drag and Cosmetic Act （the act）。本法规适用于所有的医疗器械成品制造商。如果制造商仅从事本部分有要求服从的某些过程而未从事其它过程，则只需符合其实施的过程的要求。对于Ⅰ类设备，设计控制仅适用于Sec.820.30（a）（2）中列出的设备。本法规不适用于成品器械的部件或零件制造商，但鼓励这类制造商把本法规的适当规定作为指南来使用。人血和血液成分制造商不受本部分法规的限制，但应遵循本章606部分法规的要求。
Current good manufacturing practice (CGMP) requirements are t forth in秋之韵作文 this quality system regulation. The requirements in this part govern the methods ud in, and the facilities and controls ud for, the design, manufacture, packaging, labeling, storage, installation, and rvicing of all finished devices intended for human u. The requirements in this part are intended to ensure that finished devices will be safe and effective and otherwi in compliance with 白露的习俗the Federal Food, Drug, and Cosmetic Act (the act). This part establishes basic requirements applicable to manufacturers of finished medical devices. If a manufacturer engages in only some operations subject to the requir
ements in this part, and not in others, that manufacturer need only comply with tho requirements applicable to the operations in which it is engaged. With respect to class I devices, design controls apply only to tho devices listed in 820.30(a) This regulation does not apply to manufacturers of components or parts of finished devices, but such manufacturers are encouraged to u appropriate provisions of this regulation as guidance. Manufacturers of human blood and blood components are not subject to this part, but are subject to part 606 of this chapter.
Manufacturers of human cells, tissues, and cellular and tissue-bad products (HCT/Ps), as defined in 1271. .3(d) of this chapter, that are medical devices (subject to premarket review or notification, or exempt from notification, under an application submitted under the device provisions of the act or under a biological product licen application under ction 351 of the Public Health Service Act) are subject to this part and are also subject to the donor-eligibility procedures t forth in part 1271 subpart C of this chapter and applicable current good tissue practice procedures in part 1271 subpart D of this chapter. In the event of a conflict between applicable regulations in part 1271 and in other parts of
this chapter, the regulation specifically applicable to the device in question shall superde the more general.
（2） 本部分的规定适用于本部分定义的预期用于人体的所有成品器械，不论其在美国(包含:美国我的使命任何州或领土,哥伦比亚特区,波多黎各联邦)本土制造还是进口cea,提供进口的产品。
(2) The provisions of this part shall be applicable to any finished device as defined in this part, intended for human u, that is manufactured, imported, or offered for import in any State or Territory of the United States, the District of Columbia, or the Commonwealth of Puerto Rico.
（3） 在本法规中“适用时”（where appropriate）出现过多次。当要求根据“where appropriate”被认为是合格时，其要求应被认为是“适用的”（appropriate），除非组织能提供文件证明其理由。如果不执行预期结果会导致产品不符合其特定的要求，或组织不需要执行任何必要的纠正措施，那么要求就是适用的（appropriate）。
(3) In this regulation the term "where appropriate" is ud veral times. When a require
ment is qualified by "where appropriate," it is deemed to be "appropriate" unless the manufacturer can document justification otherwi. A requirement is "appropriate" if non-implementation could reasonably be expected to result in the product not meeting its specified requirements or the manufacturer not being able to carry out any necessary corrective action.
（b） 限制。除非特别规定，则本部分质量体系法规是本章其它部分法规的补充要求。在不能符合所有适用的法规，包括本章此部分和其它部分的情况，特别是对讨论中的设备，此法规应取代其它通用要求。
(b) The quality system regulation in this part supplements regulations in other parts of this chapter except where explicitly stated otherwi. In the event of a conflict between applicable regulations in this part and in other parts of this chapter, the regulations specifically applicable to the device in question shall superde any other generally applicable requirements.
（c） 权限。PART820是在（21U.S.C.法令351、352、360、360c、360d、360e、360h
、360i、360j、360l、370、374、381、383中）501、502、510、513、514、515、518、519、520、522、701、704、801、803下建立并发布的。不符合本部分（Part 820）的任何适用的规定，依据法令ction 501（h）条款，可判定该产品为伪劣产品。这类产品及对此不符合负责的任何个人，将依法被起诉。
(c)Authority. Part 820 is established and issued under authority of ctions 501, 502, 510, 513, 514, 515, 518, 519, 520, 522, 701, 704, 801, 803 of the act (21 U.S.C. 351, 352, 360, 360c, 360d, 360e, 360h, 360i, 360j, 360l, 371, 374, 381, 383). The failure to comply with any applicable provision in this part renders a device adulterated under ction 501(h) of the act. Such a device, as well as any person responsible for the failure to comply, is subject to regulatory action.
